Meta $META has had a rough 2026. The stock is down over 25% from its highs and even touched a 46-week low back in March, before bouncing back into the $600–$615 range. Whenever a big stock falls this hard, people start asking the same question: Are the people running the company buying the dip? The honest answer is no. $META top executives (Zuckerberg, COO Javier Olivan, CFO Susan Li, CTO Andrew Bosworth, and the rest of the leadership team) haven't made a single open-market purchase of their own stock in the last 12 months. Meanwhile, they've sold about 150 times. That's not necessarily a warning sign, since most of that selling happens automatically through pre-scheduled trading plans tied to compensation, not because someone woke up and decided to sell. But it does mean insider buying just isn't where the story is right now. The real story is what institutions are doing. While executives have been selling, professional money managers have quietly been doing the opposite. Looking at Q1 2026 filings, several funds grew their $META positions. Hamilton Capital Partners added over 25,000 shares, more than doubling its position. Tokio Marine Asset Management grew its stake by roughly 21%. Earned Wealth Advisors increased its holding by over 40%. Baskin Financial Services also added shares, building out a position worth over $30 million. This isn't just a handful of isolated examples either. Across all institutional holders of $META stock, 480 funds increased their positions last quarter, compared to only 336 that trimmed theirs. Institutions now own roughly 80% of $META available shares, which is a level that usually reflects real long-term conviction rather than passive index tracking. So why does this matter more than insider buying would? A single executive buying a few hundred thousand dollars of stock makes for a nice headline, but it's a small move relative to their total pay and net worth, so it rarely tells you much. Institutional buying is a different game. When several independent, professionally run funds all decide to add to the same stock in the same quarter, it usually means they're looking at the same numbers and reaching the same conclusion: that the sell-off pushed the price below what they consider fair value. That view lines up with the sentiment on Wall Street too. $META has been called the cheapest stock among the "Magnificent Seven" after this year's decline, and some analyst price targets sit as high as $860 to $900, which would mean real upside from where the stock trades today if the company's AI investments start paying off. With that said, institutional buying isn't a guarantee either. Funds add to positions for all kinds of reasons that have nothing to do with a strong opinion on the stock, like rebalancing or tracking an index. When you put both signals side by side, the picture becomes more clear. Company insiders are selling shares on autopilot through routine compensation plans, while independent institutional investors are actively choosing to add to their positions during a period of weakness. Of the two signals, the institutional one tells you more, because it reflects an active decision rather than a scheduled one. The takeaway here is simple: don't get distracted chasing headlines about insider buying. Pay attention to where the institutional money is moving. Right now, it's moving toward $META, even while the stock sits well below its highs. Are you buying $META at these prices?
1,750 views
2 Comments
Jeffrey Ho@investor282 · 10d
Yea I bought some, only about 50K though
See the full comment section 👀Sign up for the full Blossom experience!
